A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (final 5-year data)

被引:0
|
作者
Klareskog, L
Wajdula, J
Pedersen, R
Yeh, P
机构
[1] Dept Med, Rheumatol Unit, Stockholm, Sweden
[2] Wyeth Ayerst Res, Med Affairs, Collegeville, PA USA
[3] Wyeth Ayerst Res, Clin Res, Collegeville, PA USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:254 / 254
页数:1
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy Of Certolizumab Pegol In Combination With Methotrexate In The Treatment Of Rheumatoid Arthritis: 5-Year Results From a 52-Week Randomized Controlled Trial and Open-Label Extension Study
    Keystone, Edward
    Landewe, Robert
    van Vollenhoven, Ronald
    Combe, Bernard
    Strand, Vibeke
    Mease, Philip J.
    Shaughnessy, Laura
    VanLunen, Brenda
    van der Heijde, Desiree
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S596 - S597
  • [32] Sustained efficacy and long-term safety of erenumab in patients with episodic migraine: 4+year results of a 5-year, open-label treatment period
    Ashina, Messoud
    Goadsby, Peter J.
    Reuter, Uwe
    Silberstein, Stephen
    Dodick, David W.
    Chou, Denise E.
    Pandhi, Shaloo
    Xue, Fei
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel D.
    [J]. CEPHALALGIA, 2019, 39 (1_SUPPL) : 365 - 366
  • [33] Sustained Efficacy and Long-term Safety of Erenumab in Patients with Episodic Migraine: 4+Year Results of a 5-Year, Open-Label Extension Study
    Ashina, M.
    Goadsby, P. J.
    Reuter, U.
    Silberstein, S. D.
    Dodick, D. W.
    Chou, D. E.
    Klatt, J.
    Xue, F.
    Zhang, F.
    Cheng, S.
    Mikol, D. D.
    [J]. HEADACHE, 2019, 59 : 25 - 25
  • [34] Randomized controlled trial of 25 mg vs. 50 mg Enbrel® (etanercept) twice weekly in rheumatoid arthritis (RA).
    Schiff, M
    Mease, P
    Weinblatt, M
    Moreland, L
    Burge, D
    [J]. ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S391 - S391
  • [35] LONG-TERM SAFETY AND EFFICACY OF OLOKIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS - RESULT OF AN OPEN-LABEL EXTENSION STUDY, CREDO4
    Feist, E.
    Nasonov, E.
    Luggen, M.
    Fatenejad, S.
    Grishin, S.
    Samsonov, M.
    Fleischmann, R. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 593 - 593
  • [36] Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis
    Silverman, E
    Spiegel, L
    Hawkins, D
    Petty, R
    Goldsmith, D
    Schanberg, L
    Duffy, C
    Howard, P
    Strand, V
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 554 - 562
  • [37] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis.
    Keystone, Edward C.
    Taylor, Peter C.
    Genovese, Mark C.
    Schlichting, Douglas E.
    De La Torre, Inmaculada
    Beattie, Scott D.
    Rooney, Terence
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1232 - S1232
  • [38] Safety and efficacy of tofacitinib for up to 9.5 years in the treatment of rheumatoid arthritis: final results of a global, open-label, long-term extension study
    Jürgen Wollenhaupt
    Eun-Bong Lee
    Jeffrey R. Curtis
    Joel Silverfield
    Ketti Terry
    Koshika Soma
    Chris Mojcik
    Ryan DeMasi
    Sander Strengholt
    Kenneth Kwok
    Irina Lazariciu
    Lisy Wang
    Stanley Cohen
    [J]. Arthritis Research & Therapy, 21
  • [39] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB OR ADALIMUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: 5-YEAR DATA FROM THE SELECT-COMPARE STUDY
    Fleischmann, R. M.
    Swierkot, J.
    Penn, S.
    Durez, P.
    Bessette, L.
    Bu, X.
    Khan, N.
    Li, Y.
    Peterfy, C.
    Tanaka, Y.
    Mysler, E.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 725 - 726
  • [40] Long-Term Safety and Efficacy of Rotigotine in Patients with Idiopathic RLS: 5-Year Results from a Prospective Multinational Open-Label FollowUp Study
    Hogl, Birgit
    Trenkwalder, Claudia
    Garcia-Borreguero, Diego
    Kohnen, Ralf
    Poewe, Werner
    Stiasny-Kolster, Karin
    Bauer, Lars
    Fichtner, Andreas
    Schollmayer, Erwin
    Oertel, Wolgang
    [J]. NEUROLOGY, 2010, 74 (09) : A106 - A106